Monthly Archives: July 2013

MiTy Kids Ethics Submissions and Site Activation

We are very excited to announce that we are nearing site activation at multiple centres! For sites preparing to submit for ethics approval, we would like to remind you to please send your informed consent form, with institutional requirements and using tracked changes, to us for review before submitting to your ethics boards. We understand […]

Read More

Updates: EnLite Approval, Medtronic Disclosure Statement and Biorepository Collection

Greetings Collaborators, There are three updates for the CONCEPTT trial. How they affect your site is dependent on whether your site is in Canada or an International site. 1) EnLite Sensor Licensing in Canada (Canada) The Medtronic EnLite Sensor was licensed for use in Canada, effective February 15, 2013. You may have submitted an investigational […]

Read More

Domperidone and Contraindicated Medications

Dear Empower Collaborators, We hope you are enjoying the beginning of summer, or winter for our sites in the Southern hemisphere! We are working diligently to activate our new sites and would like to take this opportunity to welcome Australia to EMPOWER! We look forward to start-up at our international sites in the near future, […]

Read More

Recruitment

We are currently in the process of surveying select sites to gain a better understanding of the challenges impeding recruitment, and the successful strategies employed to overcome these challenges. Stay tuned for the results!

Read More

Patients Created in OpenClinica

Just a friendly reminder that subject IDs are created automatically in OpenClinica the day after randomization.  Randomization information is also transferred automatically at this time into OpenClinica, and therefore it is unnecessary to fill out the “Randomization and Information” form in the Baseline event.  Hopefully, this will reduce the workload for our MiTy collaborators. *Do […]

Read More